Interindividual variability and intraindividual stability of oral fungal microbiota over time

Medical Mycology

Volumn 52, Issue 5, 2014, Pages 496-503

  Monteiro Da Silva, Filipa ^a,b   Araujo, Ricardo ^b   Sampaio Maia, Benedita ^a,b  

^a Portugal   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

fungi; mould; mycobiome; oral health; yeast

Indexed keywords

INTERNAL TRANSCRIBED SPACER; FUNGAL DNA; RIBOSOME DNA; MOUTHWASH;

ADULT; ARTICLE; ASPERGILLUS; CANDIDA; CLADOSPORIUM; FEMALE; FOLLOW UP; FUNGAL COMMUNITY; FUNGAL STRUCTURES; FUNGAL VIABILITY; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HEALTH; HUMAN; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MOULD; MOUTH CAVITY; MOUTH FLORA; MOUTH HYGIENE; NORMAL HUMAN; PENICILLIUM; RHODOTORULA; YEAST; YOUNG ADULT; BIODIVERSITY; CHEMISTRY; CLASSIFICATION; DEMOGRAPHY; DNA SEQUENCE; FUNGUS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MOUTH; INCUBATION TEMPERATURE; MORPHOLOGY; TAXON;

ADULT; BIODIVERSITY; DEMOGRAPHY; DNA, FUNGAL; DNA, RIBOSOMAL; FEMALE; FUNGI; HUMANS; MALE; MICROBIOTA; MOUTH; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

FUNGI;

EID: 84903126304     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myu027     Document Type: Article

References (29)

1. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
2. Filoche S, Wong L, Sissons CH. Oral biofilms: emerging concepts in microbial ecology. J Dent Res 2010; 89: 8-18.
3. Ghannoum MA, Jurevic RJ, Mukherjee PK et al., Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog 2010; 6: e1000713.
4. Zarco MF, Vess TJ, Ginsburg GS. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis 2012; 18: 109-120.
5. Scully C, el-Kabir M, Samaranayake LP. Candida and oral can-didosis: a review. Crit Rev Oral Biol Med 1994; 5: 125-157.
6. Lim CS, Rosli R, Seow HF, Chong PP. Candida and invasive candidiasis: back to basics. Eur J Clin Microbiol Infect Dis 2012; 31: 21-31.
7. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of noso-comial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-644.
8. Egan MW, Spratt DA, Ng YL et al., Prevalence of yeasts in saliva and root canals of teeth associated with apical periodontitis. Int Endod J 2002; 35: 321-329.
9. Miranda TT, Vianna CR, Rodrigues L, et al. Diversity and frequency of yeasts from the dorsum of the tongue and necrotic root canals associated with primary apical periodontitis. Int Endod J 2009; 42: 839-844.
10. Monteiro-da-Silva F, Sampaio-Maia B, Pereira M de L, Araujo R. Characterization of the oral fungal microbiota in smokers and non-smokers. Eur J Oral Sci 2013; 121: 132-135.
11. WHO. WHO Oral Health Country/Area Profile Programme. http://www.mah.se/ capp/.html. Accessed 8/6August 6,/2012.
12. Larone DH. Medically Important Fungi: A Guide to Identification. 3rd ed. Washington, DC: ASM Press; 1995.
13. Epstein JB, Pearsall NN, Truelove EL. Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects. J Clin Microbiol 1980; 12: 475-476.
14. Borneman J, Hartin RJ. PCR primers that amplify fungal rRNA genes from environmental samples. Appl Environ Microbiol 2000; 66: 4356-4360.
15. Wilms R, Sass H, Kopke B, et al. Specific bacterial, archaeal, and eukaryotic communities in tidal-flat sediments along a vertical profile of several meters. Appl Environ Microbiol 2006; 72: 2756-2764.
16. Odds FC. Candida and Ccandidosis. 2nd ed. London: Bailliere Tindall; 1988.
17. Farah CS, Lynch N, McCullough MJ. Oral fungal infections: an update for the general practitioner. Aust Dent J 2010; 55: 48-54.
18. Araujo R, Cabral JP, Rodrigues AG. Air filtration systems and restrictive access conditions improve indoor air quality in clinical units: Penicillium as a general indicator of hospital indoor fungal levels. Am J Infect Control 2008; 36: 129-134.
19. Oliveira M, Ribeiro H, Delgado JL, Abreu I. Aeromycological profile of indoor and outdoor environments. J Environ Monit 2009; 11: 1360-1367.
20. Buzina W, Braun H, Freudenschuss K, et al. Fungal biodiversity-as found in nasal mucus. Med Mycol 2003; 41: 149-161.
21. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74: 877-884.
22. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 2010; 36: 1-53.
23. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317.
24. Patterson TF. Advances and challenges in management of invasive mycoses. Lancet 2005; 366: 1013-1025.
25. Vonberg RP, Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect 2006; 63: 246-254.
26. Perfect JR, Cox GM, Lee JY et al., The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillo-sis. Clin Infect Dis 2001; 33: 1824-1833.
27. Turnbaugh PJ, Ley RE, Hamady M et al., The human micro-biome project. Nature 2007; 449: 804-810.
28. Lazarevic V, Whiteson K, Hernandez D, Francois P, Schrenzel J. Study of inter-and intra-individual variations in the salivary microbiota. BMC Genomics 2010; 11: 523.
29. Lazarevic V, Whiteson K, François P, Schrenzel J. The salivary microbiome, assessed by a high-throughput and culture-independent approach. J Integr OMICS 2011; 1: 28-35.